# EDGAR Filing Document

**Accession Number:** 0001023024
**File Stem:** 0001023024-26-000040
**Filing Date:** 2026-4
**Character Count:** 2329
**Document Hash:** 0d2838cf7805de45cb80ae0a6bf99153
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001023024-26-000040.hdr.sgml**: 20260409

**ACCESSION NUMBER**: 0001023024-26-000040

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20260409

**DATE AS OF CHANGE**: 20260409

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ANI PHARMACEUTICALS INC
- **CENTRAL INDEX KEY:** 0001023024
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 582301143
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31812
- **FILM NUMBER:** 26851726

**BUSINESS ADDRESS:**
- **STREET 1:** 104 CARNEGIE CENTER DRIVE SUITE 300
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540
- **BUSINESS PHONE:** 6097591810

**MAIL ADDRESS:**
- **STREET 1:** 104 CARNEGIE CENTER DRIVE SUITE 300
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIOSANTE PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 19991228

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BEN ABRAHAM TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19991027

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, DC 20549** 

_________________________

**SCHEDULE 14A** 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

_________________________

Filed by the Registrant ⌧

Filed by a Party other than the Registrant □

Check the appropriate box:

□ Preliminary Proxy Statement

□ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

□ Definitive Proxy Statement

⌧ Definitive Additional Materials

□ Soliciting Material Pursuant to §240.14a-12

**ANI PHARMACEUTICALS, INC.**

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

⌧ No fee required.

□ Fee paid previously with preliminary materials.

□ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![defa14a_annualmeeting05202.jpg](defa14a_annualmeeting05202.jpg)

------

![defa14a_annualmeeting05202a.jpg](defa14a_annualmeeting05202a.jpg)

<br>